Recombinant Human Anti-CD3 x Anti-DLL3 Bispecific Antibody (IgG-scFv) (IGFV-H250)

Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lung cancer; Pancreatic cancer; Skin cancer; Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CD3 & DLL3

Type

IgG-scFv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Lung cancer; Pancreatic cancer; Skin cancerSolid tumors

Targets

Target 1

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Target 2

DLL3

Gene ID

10683

UniProt ID

Q9NYJ7

Alternative Names

DLL3; delta-like 3 (Drosophila); Delta-like 3; SCDO1; delta-like protein 3; delta3; drosophila Delta homolog 3; Delta like canonical notch ligand 3

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD3 x Anti-DLL3 Bispecific Antibody (IgG-scFv) (IGFV-H250). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD3 x Anti-DLL3 Bispecific Antibody (IgG-scFv) (CAT#: IGFV-H250)

Specifications

Targets

Customer Reviews and Q&As